PAVmed (PAVM) Income from Continuing Operations (2016 - 2026)

PAVmed's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 2757000.0 for Q4 2025.

• In Q4 2025, Income from Continuing Operations fell 341.42% year-over-year to 2757000.0; the TTM figure through Dec 2025 stood at 2469000.0 (up 95.03% YoY), while the FY2025 annual figure was 2469000.0, down 108.69% from the prior year.
• Income from Continuing Operations for Q4 2025 stood at 2757000.0, up from 6011000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 18623000.0 in Q1 2025, with the low at 29932000.0 in Q3 2022.
• The 5-year median for Income from Continuing Operations is 17408000.0 (2023), against an average of 14388526.32.
• Peak annual rise in Income from Continuing Operations reached 200.6% in 2025, while the deepest fall reached 341.42% in 2025.
• PAVmed's Income from Continuing Operations stood at 19679000.0 in 2021, then dropped by 24.86% to 24572000.0 in 2022, then advanced by 29.16% to 17408000.0 in 2023, then jumped by 106.56% to 1142000.0 in 2024, then slumped by 341.42% to 2757000.0 in 2025.
• Business Quant data shows PAVM's Income from Continuing Operations at 2757000.0 in Q4 2025, 6011000.0 in Q3 2025, and 12324000.0 in Q2 2025.